A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.
Recs
harlancr
(< 20)
Submitted: 26/04/2010 18:55:18 :
Start Price:
$4.41
KERX.US Score:
+51.37
lot of drugs in the pipeline. will hit on some.
Recs
twrichter
(< 20)
Submitted: 24/04/2010 20:09:00 :
Start Price:
$4.48
KERX.US Score:
+49.79
In the first quarter of 2012 the companies drug it has in testing will go to market. Other companies with similar operations are selling around $30 to $40 a share with 1 drug on the market. This company has 2 in phase 3 testing being fast tracked by the FDA and in 2012 both should be out and on the market.
Recs
blubby8
(< 20)
Submitted: 21/04/2010 10:28:45 :
Start Price:
$4.34
KERX.US Score:
+54.66
Do a little research and you'll find that KERX is not just another one hit wonder. 2 successful phase 3 trials will skyrocket this stock. Do Not Miss It!!!
Recs
dutchyshaw
(< 20)
Submitted: 20/04/2010 18:25:40 :
Start Price:
$4.29
KERX.US Score:
+56.94
With 2 FDA Fastracks and a multi-cancer drug in Phase II and III trials, KERX is poised to leap. It also has a phosphate binder for late stage dialysis patients that improves their iron absorption.
Recs
skillzmillz1
(65.10)
Submitted: 19/04/2010 22:28:28 :
Start Price:
$4.45
KERX.US Score:
+49.63
Great Pipeline of drugs that have a chance for fda approval in next year, positive eps, one drug that is industry changing
Recs
DNAJUICE
(< 20)
Submitted: 14/04/2010 15:54:40 :
Start Price:
$4.76
KERX.US Score:
+38.10
Great pipline with 2 drugs granted FDA fast-track status. This is a money maker.
Recs
TMFBiologyFool
(99.13)
Submitted: 05/04/2010 12:29:44 :
Start Price:
$3.28
KERX.US Score:
-113.87
A 20% increase because of a fast-track designation? Really?
Recs
kpdobe
(26.61)
Submitted: 30/03/2010 12:55:52 :
Start Price:
$2.82
KERX.US Score:
+152.85
Very good fundamentals. Execllent growth in the longterm here.
Recs
Guitarmaniatico
(< 20)
Submitted: 24/03/2010 14:49:18 :
Start Price:
$2.98
KERX.US Score:
+136.62
I´ve made recommendations on various stocks that are going to double its price and they all did!
Now I want to warn the Fool community for this: KERX
The period a pharmaceutical stock invest a lot in a new drug is previous the phase 1, now this stock has TWO big drugs that are finishing the phase 2. This period comes usually with a loss in earnings per share.
If you want a juicy 100% gain, please trust me as people did in my PACR, CIGX, and other stocks recommendations.
Tomorrow is the earnings conference and you would see and absolutely BEAT EXPECTATIONS, the stock tomorrow probably move up 10 to 20% or more!
But the good things will came when the FDA approves the two new drugs, and trust me, you will see it from $2.98 (today) to $12 – $18. As I said before on other stocks: don´t you dare to miss this opportunity! Move fast before Wall Street.
Recs
Eversar
(98.24)
Submitted: 22/02/2010 09:36:35 :
Start Price:
$2.50
KERX.US Score:
+182.58
Upward Wedge
Recs
TheRoust
(< 20)
Submitted: 16/02/2010 11:50:48 :
Start Price:
$2.50
KERX.US Score:
+179.92
The management is on track to move this company in the right direction.
Recs
recgraph
(73.62)
Submitted: 28/01/2010 12:01:44 :
Start Price:
$2.71
KERX.US Score:
+157.11
This company has ongoing phase III trials of a potential multi cancer blockbuster drug that has been fast tracked for approval by the FDA. The fundamentals look good, lots of cash, small float, much insider buying, excellent management team and zero debt. Plus other important cancer drugs in the pipeline that will benefit the world. Buy and hold for substantial gains, IMHO.
Recs
LexTNZorro
(78.84)
Submitted: 10/01/2010 10:36:37 :
Start Price:
$2.90
KERX.US Score:
+142.11
http://seekingalpha.com/article/181734-keryx-biopharma-a-well-capitalized-comeback-story-with-multiple-catalysts?source=feed
Recs
ebitdat
(24.16)
Submitted: 22/12/2009 21:06:08 :
Start Price:
$2.72
KERX.US Score:
+157.00
Great balance sheet, strong product. Way undervalued
Recs
VietSpeed
(26.65)
Submitted: 19/11/2009 03:16:46 :
Start Price:
$2.36
KERX.US Score:
+199.93
The future.
Recs
waysane
(< 20)
Submitted: 10/11/2009 13:36:43 :
Start Price:
$2.14
KERX.US Score:
+235.11
Big Pharm always makes money
Recs
harlanror
(< 20)
Submitted: 09/11/2009 16:05:49 :
Start Price:
$2.29
KERX.US Score:
+210.30
this company has some strong drugs in the pipeline, should hit on many of them. stock could double or triple.
Recs
sOulbAitIsAFool
(< 20)
Submitted: 18/10/2009 19:47:09 :
Start Price:
$2.22
KERX.US Score:
+221.31
If you have a few extra coins, this is the one.
Recs
mmerinpa
(< 20)
Submitted: 27/09/2009 04:28:10 :
Start Price:
$2.62
KERX.US Score:
+158.61
it has two good drugs in phase 3 trials and just got approval in UK for one of them, a new class of drugs to treat multiple myeloma.
Recs
subzero701
(< 20)
Submitted: 25/09/2009 11:15:04 :
Start Price:
$2.77
KERX.US Score:
+141.58
Key developments have been announced to increase the likelyhood of new drugs being brought. The stock is selling at a major discount from its daily average moving price in past years.
For details about CAPS-UK, and the conditions you agree to be bound by, please see our Terms and Conditions.
This page brought to you by USEQ\WEB21.
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 41 - 60 of 75 : « Previous 1 2 3 4 Next »